Is the recent surge in Jio Financial justified?
Yash Vora | Views On News Shankar Sharma Acquires 3,500,000 Shares in a Surging Penny StockThe NSE-only listed stock has rallied around 40% in 2024 so far. | Equitymaster | Views On News Which Companies are Involved in the Bullet Train Project in India?Here are the major companies making the bullet train project a reality in India. |
Equitymaster | Views On News This Indian Tech Player is Partnering with Nvidia to Lead the AI RevolutionThis Indian high-performance computing (HPC) leader is riding the AI wave with cutting-edge solutions and strategic partnersh... | Equitymaster | Views On News If You'd Invested 100,000 in Bajaj Finance Stock 10 Years Ago, Here's How Much You'd Have TodayGiven Bajaj Finance's multibagger gains over the past 10 years, has its valuation outpaced the broader market's growth? |
Tanushree Banerjee | Views On News Pharma Stocks Watchlist to Profit from Patent CliffThe last time such a cliff occurred during 2011-15 and offered substantial upside in pharma stocks. | Equitymaster | Views On News Top EV Shares in India 2024: EV Companies to Add to Your WatchlistThese companies are prime candidates to benefit from this decade's EV investment boom. |
Equitymaster | Views On News 5 Stocks that Could Deliver Superb Gains During a Copper SupercycleSeveral factors indicate that copper demand is likely to exceed supply, which could potentially have a positive impact on the... | Richa Agarwal | Profit Hunter Make Better Returns than Big Investors in the MarketCan you beat the big boys of the stock market at their own game? Read this... | Bhavin Dedhia | Profit Hunter Stocks Profiting from the Surge in Travel Spending in IndiaA change in the Indian mindset towards travel & tourism is benefitting these companies. | Ayesha Shetty | Views On News Why Bank of India Share Price is FallingThis PSU stock is down more than 10% today. Here's why. |
After opening the day marginally higher, Indian share markets continued the momentum as the session progressed and ended the day higher.
Is this week's market correction serious enough to cause concern? Find out...
Sarit Panackal | Private Briefing Why it's Probably Not the Time to Sell Your StocksIs the market getting closer to the level where you should sell your stocks? Find out... | Rahul Shah | Double Income New Recommendation AlertHere's the May edition of Rahul Shah's Double Income... |
Tanushree Banerjee | StockSelect Special Report Released: StockSelectRead the latest StockSelect special report here... | |
Rahul Shah | Exponential Profits New Recommendation AlertHere's the April edition of Rahul Shah's Exponential Profits... | Tanushree Banerjee | StockSelect New Recommendation AlertHere's the April edition of Tanushree Banerjee's StockSelect... |
Richa Agarwal | Hidden Treasure New Recommendation AlertHere's the April edition of Richa Agarwal's Hidden Treasure... | Rahul Shah | Midcap Value Alert New Recommendation AlertHere's the April edition of Rahul Shah's Midcap Value Alert... |
Rahul Shah | Exponential Profits Special Report Released: Exponential Profits Special ReportRead the latest Exponential Profits special report here... | Rahul Shah | Double Income New Recommendation AlertHere's the April edition of Rahul Shah's Double Income... |
The prospects of pharma stocks globally are tied to what is called the patent lifecycle of drugs.